New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Roundhill Investments›OZEM

OZEM

Roundhill GLP-1 & Weight Loss ETF

Active ETF Equity Theme: Tomorrow's Treatments

Not rated

The OZEM Exchange Traded Fund (ETF) is provided by Roundhill Investments. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Diversification

Data as of 06/30/26

No. of holdings

Effective diversification

15.5

Total weight of top 15 holdings

82.24%

Top 15 Holdings

Data as of 06/30/26

Novo Nordisk A/S

13.29%

Eli Lilly & Co.

13.07%

Pfizer Inc.

6.58%

Kailera Therapeutics, Inc.

6.00%

Viking Therapeutics, Inc.

5.84%

CSPC Pharmaceutical Group Ltd.

5.22%

Chugai Pharmaceutical Co., Ltd.

4.53%

Ascletis Pharma, Inc.

3.95%

Zealand Pharma A/S

3.93%

Amgen, Inc.

3.89%

AstraZeneca PLC

3.89%

Hanmi Pharmaceutical Co., Ltd.

3.33%

Roche Holding AG

3.12%

Structure Therapeutics, Inc.

2.89%

MBX Biosciences, Inc.

2.71%

Sector exposures

Data as of 06/30/26

Healthcare

Unavailable

020%40%60%80%100%

Country exposures

Data as of 06/30/26

USA

Denmark

China

Japan

United Kingdom

Republic of Korea

Switzerland

Hong Kong

Unavailable

Other

010%20%30%40%50%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Roundhill GLP-1 & Weight Loss ETF

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US